IDEAS home Printed from https://ideas.repec.org/a/spr/eujhec/v11y2010i6p525-531.html
   My bibliography  Save this article

The direct, indirect and intangible costs of visual impairment caused by neovascular age-related macular degeneration

Author

Listed:
  • Kathleen Ke

Abstract

No abstract is available for this item.

Suggested Citation

  • Kathleen Ke, 2010. "The direct, indirect and intangible costs of visual impairment caused by neovascular age-related macular degeneration," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(6), pages 525-531, December.
    • Handle: RePEc:spr:eujhec:v:11:y:2010:i:6:p:525-531
    DOI: 10.1007/s10198-009-0207-9
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/s10198-009-0207-9
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/s10198-009-0207-9?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Alan Cruess & Gergana Zlateva & Xiao Xu & Gièle Soubrane & Daniel Pauleikhoff & Andrew Lotery & Jordi Mones & Ronald Buggage & Caroline Schaefer & Tyler Knight & Thomas Goss, 2008. "Economic Burden of Bilateral Neovascular Age-Related Macular Degeneration," PharmacoEconomics, Springer, vol. 26(1), pages 57-73, January.
    2. Livio Garattini & Emanuela Castelnuovo & Paolo Lanzetta & Cecilia Viscarra & Elena Ricci & Fabio Parazzini, 2004. "Direct medical costs of age-related macular degeneration in Italian hospital ophthalmology departments," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 5(1), pages 22-27, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Bjoern Schwander, 2014. "Early health economic evaluation of the future potential of next generation artificial vision systems for treating blindness in Germany," Health Economics Review, Springer, vol. 4(1), pages 1-10, December.
    2. Alberto Ferreira & Alexandros Sagkriotis & Melvin Olson & Jingsong Lu & Charles Makin & Fran Milnes, 2015. "Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA," PLOS ONE, Public Library of Science, vol. 10(7), pages 1-12, July.
    3. Bennion, Amy E. & Shaw, Rachel L. & Gibson, Jonathan M., 2012. "What do we know about the experience of age related macular degeneration? A systematic review and meta-synthesis of qualitative research," Social Science & Medicine, Elsevier, vol. 75(6), pages 976-985.
    4. Ra Ho & Lina D Song & Jin A Choi & Donghyun Jee, 2018. "The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-14, October.
    5. Yuliya Chuvarayan & Robert P. Finger & Juliane Köberlein-Neu, 2020. "Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(1), pages 115-127, February.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:11:y:2010:i:6:p:525-531. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.